Gladius Capital Management’s Cullinan Oncology CGEM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,578	Closed	-$27.7K	–	300
2023 Q2	$27.7K	Sell	2,578 -400	-13%	-$4.3K	﹤0.01%	182
2023 Q1	$30.5K	Sell	2,978 -16	-0.5%	-$164	﹤0.01%	202
2022 Q4	$31.6K	Buy	2,994 +240	+9%	+$2.53K	﹤0.01%	245
2022 Q3	$36K	Buy	+2,754	New	+$36K	﹤0.01%	181